Escobar MF, Delgado MP, Jaramillo C

Language: Spanish
References: 13
Page: 265-270
PDF size: 70.23 Kb.

ABSTRACT

Background: Acute respiratory infection is considered one of the main causes of morbidity worldwide; it can be associated to serious complications. A great number of viral and bacterial agents have been implicated in the development of the disease. Recently, importance has been given to Mycoplasma pneumoniae as a respiratory pathogen, since epidemiologic studies suggest a raise in the incidence of diseases due to this microorganism. Nevertheless, nowadays clinical laboratories deal with a variety of difficulties in the diagnosis of this agent, raising the need for other molecular methods for its detection. Objective: The detection of M. pneumoniae in children with respiratory infection by a PCR-in vitro hybridization technique. Methods: 36 oropharyngeal swabs from children between 0 and 9 years of age with respiratory infection were analyzed by PCR-in vitro hybridization; 36% had pneumonia and 30% bronchopneumonia. Results: The implementation of the PCR-in vitro hybridization for the detection of M. pneumoniae in patients with respiratory infection allowed the detection of the pathogen’s DNA in 67% of the patients studied. Of these, 33% had pneumonia. Conclusion: PCR-in vitro hybridization is useful for the detection of M. pneumoniae. Our results show the frequent presence of nucleic acids of M. pneumoniae in the samples studied and suggest this microorganism can be a frequent causal agent of respiratory infection.

REFERENCES

1. Rosete DP, Archundia FJ, Cabello C, Manajarrez ME. Patogenia de las infecciones respiratorias por virus. Rev Inst Nal de Enf Resp Mex 2002;15:239-254.

2. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429-437.

3. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003;36:267-278.

4. Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr 2001;160:483-491.

5. Heath PT. Epidemiology and bacteriology of bacterial pneumonias. Paediatr Respir Rev 2000;1:4-7.

6. Martínez O. Neumonía por Mycoplasma pneumoniae en el Hospital de la Misericordia. Actual Pediatr 1993;3:166-170.

7. Trujillo H, Robledo J, Díaz FJ, et al. Neumonía por Mycoplasma pneumoniae en 107 niños de Medellín. Actual Pediatr 1998;8:20-24.

8. Gupta SK, Sarosi GA. The role of atypical pathogens in community- pneumonia. Med Clin North Am 2001;85:1349-1361.

9. Loens K, Ieven M, Ursi D, et al. Detection of Mycoplasma pneumoniae by real-time nucleic acid sequence-based amplification. J Clin Microbiol 2003;41:4448-4450.

10. Waris ME, Toikka P, Saarinen T, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 1998;36:3155-3159.

11. Saiki RK, Scharf S, Falooma F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction sites analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-1354.

12. Honeybourne D. Community-acquired pneumonia in ambulatory patients: relative importance of atypical pathogens. Int J Antimicrob Agents 2001;18 Suppl:57-61.

13. Ursi D, Ieven M, Noordhoek GT, Ritzler M, Zandleven H, Altwegg M. An interlaboratory comparison for detection of Mycoplasma pneumoniae in respiratory samples by polymerase chain reaction. J Microbiol Methods 2003;53:289-294.